Accelerated partial breast irradiation: A review and description of an early North American surgical experience with the intrabeam delivery system

Cancer Control

Volumn 19, Issue 4, 2012, Pages 295-308

  Deneve, Jeremiah L ^a   Hoefer, Richard A ^b   Harris, Eleanor E R ^a   Laronga, Christine ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b Dorothy G Hoefer Comprehensive Breast Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; TRASTUZUMAB;

ACCELERATED PARTIAL BREAST IRRADIATION; ADJUVANT THERAPY; ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BALLOON CATHETER; BRACHYTHERAPY; BRACHYTHERAPY DEVICE; BREAST CANCER; CANCER RADIOTHERAPY; CELLULITIS; CLINICAL ARTICLE; CLINICAL PRACTICE; COMPUTER ASSISTED RADIOTHERAPY; ERYTHEMA; FEMALE; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; HYPEREMIA; INSTITUTIONAL REVIEW; INTENSITY MODULATED RADIATION THERAPY; INTRAOPERATIVE RADIOTHERAPY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MEDICAL DECISION MAKING; MEDICAL LITERATURE; MORBIDITY; NORTH AMERICA; ONCOGENE NEU; OPERATION DURATION; OUTCOME ASSESSMENT; PARTIAL MASTECTOMY; PATIENT SELECTION; PHOTON THERAPY; POSTOPERATIVE PERIOD; RADIATION DOSE DISTRIBUTION; SENTINEL LYMPH NODE BIOPSY; SEROMA; SUBCUTANEOUS TISSUE; SURGICAL DRAINAGE; TISSUE FLAP; TREATMENT OUTCOME; TUMOR SUPPRESSOR GENE; TUMOR VOLUME;

EID: 84867033329     PISSN: 10732748     EISSN: 15262359     Source Type: Journal    
DOI: 10.1177/107327481201900406     Document Type: Article

References (107)

1. Clarke M, Collins R, Darby S, et al. Eff ects of radiotherapy and of diff erences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005;366(9503): 2087-2106
2. van Dongen JA, Voogd AC, Fentiman IS, et al. Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial. J Natl Cancer Inst. 2000;92(14):1143-1150
3. Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002;347(16): 1233-1241
4. Veronesi U, Cascinelli N, Mariani L, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med. 2002;347(16):1227-1232
5. Bartelink H, Horiot JC, Poortmans PM, et al. Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881- 10882 trial. J Clin Oncol. 2007;25(22):3259-3265
6. Belkacemi Y, Chauvet MP, Giard S, et al. Partial breast irradiation as sole therapy for low risk breast carcinoma: early toxicity, cosmesis and quality of life results of a MammoSite brachytherapy phase II study. Radiother Oncol. 2009;90(1):23-29
7. Benitez PR, Keisch ME, Vicini F, et al. Five-year results: the initial clinical trial of MammoSite balloon brachytherapy for partial breast irradiation in earlystage breast cancer. Am J Surg. 2007;194(4):456-462
8. Polgár C, Fodor J, Major T, et al. Breast-conserving treatment with partial or whole breast irradiation for low-risk invasive breast carcinoma--5-year results of a randomized trial. Int J Radiat Oncol Biol Phys. 2007;69(3):694-702
9. Vaidya JS, Tobias JS, Baum M, et al. TARGeted Intraoperative radiotherapy (TARGIT): an innovative approach to partial-breast irradiation. Semin Radiat Oncol. 2005;15(2):84-91
10. Polgár C, Strnad V, Major T. Brachytherapy for partial breast irradiation: the European experience. Semin Radiat Oncol. 2005;15(2):116-122
11. Vicini FA, Arthur DW. Breast brachytherapy: North American experience. Semin Radiat Oncol. 2005;15(2):108-115
12. Clarke DH, Le MG, Sarrazin D, et al. Analysis of local-regional relapses in patients with early breast cancers treated by excision and radiotherapy: experience of the Institut Gustave-Roussy. Int J Radiat Oncol Biol Phys. 1985;11(1):137-145
13. Morrow M. Rational local therapy for breast cancer. N Engl J Med. 2002;347(16):1270-1271
14. Polgár C, Major T. Current status and perspectives of brachytherapy for breast cancer. Int J Clin Oncol. 2009;14(1):7-24
15. Fentiman IS, Poole C, Tong D, et al. Inadequacy of iridium implant as sole radiation treatment for operable breast cancer. Eur J Cancer. 1996;32A(4):608-611
16. Magee B, Swindell R, Harris M, et al. Prognostic factors for breast recurrence after conservative breast surgery and radiotherapy: results from a randomised trial. Radiother Oncol. 1996;39(3):223-227
17. Poti Z, Nemeskeri C, Fekeshazy A, et al. Partial breast irradiation with interstitial 60CO brachytherapy results in frequent grade 3 or 4 toxicity. Evidence based on a 12-year follow-up of 70 patients. Int J Radiat Oncol Biol Phys. 2004;58(4):1022-1033
18. Perera F, Yu E, Engel J, et al. Patterns of breast recurrence in a pilot study of brachytherapy confined to the lumpectomy site for early breast cancer with six years' minimum follow-up. Int J Radiat Oncol Biol Phys. 2003;57(5):1239-1246
19. Vicini F, Arthur D, Polgar C, et al. Defining the efficacy of accelerated partial breast irradiation: the importance of proper patient selection, optimal quality assurance, and common sense. Int J Radiat Oncol Biol Phys. 2003;57(5):1210-1213
20. Dodwell DJ, Dyker K, Brown J, et al. A randomised study of whole-breast vs tumour-bed irradiation after local excision and axillary dissection for early breast cancer. Clin Oncol (R Coll Radiol). 2005;17(8):618-622
21. Krishnan L, Jewell WR, Tawfik OW, et al. Breast conservation therapy with tumor bed irradiation alone in a selected group of patients with stage I breast cancer. Breast J. 2001;7(2):91-96
22. Niehoff P, Polgár C, Ostertag H, et al. Clinical experience with the MammoSite radiation therapy system for brachytherapy of breast cancer: results from an international phase II trial. Radiother Oncol. 2006;79(3):316-320
23. Ott OJ, Hildebrandt G, Potter R, et al. Accelerated partial breast irradiation with multi-catheter brachytherapy: Local control, side eff ects and cosmetic outcome for 274 patients. Results of the German-Austrian multi-centre trial. Radiother Oncol. 2007;82(3):281-286
24. Polgár C, Major T, Fodor J, et al. High-dose-rate brachytherapy alone versus whole breast radiotherapy with or without tumor bed boost after breastconserving surgery: seven-year results of a comparative study. Int J Radiat Oncol Biol Phys. 2004;60(4):1173-1181
25. Wazer DE, Kaufman S, Cuttino L, et al. Accelerated partial breast irradiation: an analysis of variables associated with late toxicity and long-term cosmetic outcome after high-dose-rate interstitial brachytherapy. Int J Radiat Oncol Biol Phys. 2006;64(2):489-495
26. King TA, Bolton JS, Kuske RR, et al. Long-term results of wide-field brachytherapy as the sole method of radiation therapy after segmental mastectomy for T(is,1,2) breast cancer. Am J Surg. 2000;180(4):299-304
27. Gomez-Iturriaga A, Pina L, Cambeiro M, et al. Early breast cancer treated with conservative surgery, adjuvant chemotherapy, and delayed accelerated partial breast irradiation with high-dose-rate brachytherapy. Brachytherapy. 2008;7(4):310-315
28. Patel RR, Christensen ME, Hodge CW, et al. Clinical outcome analysis in "high-risk" versus "low-risk" patients eligible for national surgical adjuvant breast and bowel B-39/radiation therapy oncology group 0413 trial: five-year results. Int J Radiat Oncol Biol Phys. 2008;70(4):970-973
29. Smith BD, Arthur DW, Buchholz TA, et al. Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO). Int J Radiat Oncol Biol Phys. 2009;74(4):987-1001
30. Polgár C, Fodor J, Major T, et al. The role of boost irradiation in the conservative treatment of stage I-II breast cancer. Pathol Oncol Res. 2001;7(4):241-250
31. Polgár C, Fodor J, Orosz Z, et al. Electron and high-dose-rate brachytherapy boost in the conservative treatment of stage I-II breast cancer first results of the randomized Budapest boost trial. Strahlenther Onkol. 2002;178(11):615-623
32. Anscher MS, Jones P, Prosnitz LR, et al. Local failure and margin status in early-stage breast carcinoma treated with conservation surgery and radiation therapy. Ann Surg. 1993;218(1):22-28
33. Schnitt SJ, Abner A, Gelman R, et al. The relationship between microscopic margins of resection and the risk of local recurrence in patients with breast cancer treated with breast-conserving surgery and radiation therapy. Cancer. 1994;74(6):1746-1751
34. Fentiman IS, Deshmane V, Tong D, et al. Caesium(137) implant as sole radiation therapy for operable breast cancer: a phase II trial. Radiother Oncol. 2004;71(3):281-285
35. Johansson B, Karlsson L, Liljegren G, et al. Pulsed dose rate brachytherapy as the sole adjuvant radiotherapy after breast-conserving surgery of T1- T2 breast cancer: first long time results from a clinical study. Radiother Oncol. 2009;90(1):30-35
36. Arthur DW, Winter K, Kuske RR, et al. A Phase II trial of brachytherapy alone after lumpectomy for select breast cancer: tumor control and survival outcomes of RTOG 95-17. Int J Radiat Oncol Biol Phys. 2008;72(2):467-473
37. Antonucci JV, Wallace M, Goldstein NS, et al. Diff erences in patterns of failure in patients treated with accelerated partial breast irradiation versus wholebreast irradiation: a matched-pair analysis with 10-year follow-up. Int J Radiat Oncol Biol Phys. 2009;74(2):447-452
38. Rakovitch E, Pignol JP, Hanna W, et al. Significance of multifocality in ductal carcinoma in situ: outcomes of women treated with breast-conserving therapy. J Clin Oncol. 2007;25(35):5591-5596
39. Vicini F, Beitsch PD, Quiet CA, et al. Three-year analysis of treatment efficacy, cosmesis, and toxicity by the American Society of Breast Surgeons MammoSite Breast Brachytherapy Registry Trial in patients treated with accelerated partial breast irradiation (APBI). Cancer. 2008;112(4):758-766
40. van Limbergen E, van den Bogaert W, van der Schueren E, et al. Tumor excision and radiotherapy as primary treatment of breast cancer. Analysis of patient and treatment parameters and local control. Radiother Oncol. 1987;8(1):1-9
41. Elkhuizen PH, van de Vijver MJ, Hermans J, Zonderland HM, van de Velde CJ, Leer JW. Local recurrence after breast-conserving therapy for invasive breast cancer: high incidence in young patients and association with poor survival. Int J Radiat Oncol Biol Phys. 1998;40(4):859-867
42. de la Rochefordiere A, Asselain B, Campana F, et al. Age as prognostic factor in premenopausal breast carcinoma. Lancet. 1993;341(8852):1039-1043
43. Chao KK, Vicini FA, Wallace M, et al. Analysis of treatment efficacy, cosmesis, and toxicity using the MammoSite breast brachytherapy catheter to deliver accelerated partial-breast irradiation: the william beaumont hospital experience. Int J Radiat Oncol Biol Phys. 2007;69(1):32-40
44. Nose T, Komoike Y, Yoshida K, et al. A pilot study of wider use of accelerated partial breast irradiation: intraoperative margin-directed re-excision combined with sole high-dose-rate interstitial brachytherapy. Breast Cancer. 2006;13(3):289-299
45. Vaidya JS, Baum M, Tobias JS, et al. Targeted intraoperative radiotherapy (TARGIT) yields very low recurrence rates when given as a boost. Int J Radiat Oncol Biol Phys. 2006;66(5):1335-1338
46. Polgár C, Van Limbergen E, Potter R, et al. Patient selection for accelerated partial-breast irradiation (APBI) after breast-conserving surgery: recommendations of the Groupe Europeen de Curietherapie-European Society for Therapeutic Radiology and Oncology (GEC-ESTRO) breast cancer working group based on clinical evidence (2009). Radiother Oncol. 2010;94(3):264-273
47. Sundquist M, Thorstenson S, Klintenberg C, et al. Indicators of loco-regional recurrence in breast cancer. The South East Swedish Breast Cancer Group. Eur J Surg Oncol. 2000;26(4):357-362
48. Zellars RC, Hilsenbeck SG, Clark GM, et al. Prognostic value of p53 for local failure in mastectomy-treated breast cancer patients. J Clin Oncol. 2000;18(9):1906-1913
49. Fisher BJ, Perera FE, Cooke AL, et al. Long-term follow-up of axillary nodepositive breast cancer patients receiving adjuvant tamoxifen alone: patterns of recurrence. Int J Radiat Oncol Biol Phys. 1998;42(1):117-123
50. Piccart-Gebhart MJ, Procter M, Leyland-Jones B, et al. Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer. N Engl J Med. 2005;353(16):1659-1672
51. Greene FL, Page DL, Fleming ID, et al. AJCC Cancer Staging Handbook. 6th ed. New York, NY: Springer; 2002
52. Schmidt-Ullrich PN, Todor DA, Cuttino LW, et al. Virtual planning of multicatheter brachytherapy implants for accelerated partial breast irradiation. Conf Proc IEEE Eng Med Biol Soc. 2004;5:3124-3127
53. Arthur DW, Koo D, Zwicker RD, et al. Partial breast brachytherapy after lumpectomy: low-dose-rate and high-dose-rate experience. Int J Radiat Oncol Biol Phys. 2003;56(3):681-689
54. Ott OJ, Potter R, Hammer J, et al. Accelerated partial breast irradiation with iridium-192 multicatheter PDR/HDR brachytherapy. Preliminary results of the German-Austrian multicenter trial. Strahlenther Onkol. 2004;180(10):642-649
55. Sanders ME, Scroggins T, Ampil FL, et al. Accelerated partial breast irradiation in early-stage breast cancer. J Clin Oncol. 2007;25(8):996-1002
56. Vicini FA, Kestin L, Chen P, et al. Limited-field radiation therapy in the management of early-stage breast cancer. J Natl Cancer Inst. 2003;95(16):1205-1210
57. Lawenda BD, Taghian AG, Kachnic LA, et al. Dose-volume analysis of radiotherapy for T1N0 invasive breast cancer treated by local excision and partial breast irradiation by low-dose-rate interstitial implant. Int J Radiat Oncol Biol Phys. 2003;56(3):671-680
58. Strnad V, Hildebrandt G, Potter R, et al. Accelerated partial breast irradiation: 5-year results of the German-Austrian multicenter phase II trial using interstitial multicatheter brachytherapy alone after breast-conserving surgery. Int J Radiat Oncol Biol Phys. 2011;80(1):17-24
59. Keisch M, Vicini F, Kuske RR, et al. Initial clinical experience with the MammoSite breast brachytherapy applicator in women with early-stage breast cancer treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys. 2003;55(2):289-293
60. Bartelink H. Commentary on the paper "A preliminary report of intraoperative radiotherapy (IORT) in limited-stage breast cancers that are conservatively treated". A critical review of an innovative approach. Eur J Cancer. 2001;37(17):2143-2146
61. Jeruss JS, Kuerer HM, Beitsch PD, et al. Update on DCIS outcomes from the American Society of Breast Surgeons accelerated partial breast irradiation registry trial. Ann Surg Oncol. 2011;18(1):65-71
62. Chen S, Dickler A, Kirk M, et al. Patterns of failure after MammoSite brachytherapy partial breast irradiation: a detailed analysis. Int J Radiat Oncol Biol Phys. 2007;69(1):25-31
63. Khan AJ, Arthur D, Vicini F, et al. Six-Year analysis of treatment-related toxicities in patients treated with accelerated partial breast irradiation on the American Society of Breast Surgeons MammoSite Breast Brachytherapy Registry Trial. Ann Surg Oncol. 2012;19(5):1477-1483
64. Vicini F, Beitsch P, Quiet C, et al. Five-year analysis of treatment efficacy and cosmesis by the American Society of Breast Surgeons MammoSite Breast Brachytherapy Registry Trial in patients treated with accelerated partial breast irradiation. Int J Radiat Oncol Biol Phys. 2011;79(3):808-817
65. Dragun AE, Harper JL, Jenrette JM, et al. Predictors of cosmetic outcome following MammoSite breast brachytherapy: a single-institution experience of 100 patients with two years of follow-up. Int J Radiat Oncol Biol Phys. 2007;68(2):354-358
66. Haley M, Beriwal S, Heron DE, et al. MammoSite accelerated partial breast irradiation: a single-institution outcomes analysis with 2 years of followup. Brachytherapy. 2009;8(1):9-13
67. Watkins JM, Harper JL, Dragun AE, et al. Incidence and prognostic factors for seroma development after MammoSite breast brachytherapy. Brachytherapy. 2008;7(4):305-309
68. Dickler A, Patel RR, Wazer D. Breast brachytherapy devices. Expert Rev Med Devices. 2009;6(3):325-333
69. Tokita KM, Cuttino LW, Vicini FA, et al. Optimal application of the Contura multilumen balloon breast brachytherapy catheter vacuum port to deliver accelerated partial breast irradiation. Brachytherapy. 2011;10(3):184-189
70. Brown S, McLaughlin M, Pope K, et al. Initial radiation experience evaluating early tolerance and toxicities in patients undergoing accelerated partial breast irradiation using the Contura Multi-Lumen Balloon breast brachytherapy catheter. Brachytherapy. 2009;8(2):227-233
71. Israel PZ, Robbins A, Shroff P, et al. Three-year clinical outcome using the Contura multilumen balloon breast brachytherapy catheter to deliver accelerated partial breast irradiation (APBI): improving radiation standards for the optimal application of APBI. Brachytherapy. 2012;11(4):316-321
72. Beriwal S, Coon D, Kim H, et al. Multicatheter hybrid breast brachytherapy: a potential alternative for patients with inadequate skin distance. Brachytherapy. 2008;7(4):301-304
73. Dickler A, Seif N, Kirk MC, et al. A dosimetric comparison of MammoSite and ClearPath high-dose-rate breast brachytherapy devices. Brachytherapy. 2009;8(1):14-18
74. Yashar CM, Blair S, Wallace A, et al. Initial clinical experience with the Strut-Adjusted Volume Implant brachytherapy applicator for accelerated partial breast irradiation. Brachytherapy. 2009;8(4):367-372
75. Scanderbeg DJ, Yashar C, Rice R, et al. Clinical implementation of a new HDR brachytherapy device for partial breast irradiation. Radiother Oncol. 2009;90(1):36-42
76. Yashar CM, Scanderbeg D, Kuske R, et al. Initial clinical experience with the Strut-Adjusted Volume Implant (SAVI) breast brachytherapy device for accelerated partial-breast irradiation (APBI): first 100 patients with more than 1 year of follow-up. Int J Radiat Oncol Biol Phys. 2011;80(3):765-770
77. Vicini F, Winter K, Straube W, et al. A phase I/II trial to evaluate threedimensional conformal radiation therapy confined to the region of the lumpectomy cavity for Stage I/II breast carcinoma: initial report of feasibility and reproducibility of Radiation Therapy Oncology Group (RTOG) Study 0319. Int J Radiat Oncol Biol Phys. 2005;63(5):1531-1537
78. Rosen PP, Fracchia AA, Urban JA, et al. "Residual" mammary carcinoma following simulated partial mastectomy. Cancer. 1975;35(3):739-747
79. Veronesi U, Marubini E, Mariani L, et al. Radiotherapy after breast-conserving surgery in small breast carcinoma: long-term results of a randomized trial. Ann Oncol. 2001;12(7):997-1003
80. Formenti SC, Truong MT, Goldberg JD, et al. Prone accelerated partial breast irradiation after breast-conserving surgery: preliminary clinical results and dose-volume histogram analysis. Int J Radiat Oncol Biol Phys. 2004;60(2):493-504
81. Cox BW, Horst KC, Thornton S, et al. Impact of increasing margin around the lumpectomy cavity to define the planning target volume for 3D conformal external beam accelerated partial breast irradiation. Med Dosim. 2007;32(4):254-262
82. Chen PY, Wallace M, Mitchell C, et al. Four-year efficacy, cosmesis, and toxicity using three-dimensional conformal external beam radiation therapy to deliver accelerated partial breast irradiation. Int J Radiat Oncol Biol Phys. 2010;76(4):991-997
83. Vicini F, Winter K, Wong J, et al. Initial efficacy results of RTOG 0319: threedimensional conformal radiation therapy (3D-CRT) confined to the region of the lumpectomy cavity for stage I/ II breast carcinoma. Int J Radiat Oncol Biol Phys. 2010;77(4):1120-1127
84. Kozak KR, Doppke KP, Katz A, et al. Dosimetric comparison of two diff erent three-dimensional conformal external beam accelerated partial breast irradiation techniques. Int J Radiat Oncol Biol Phys. 2006;65(2):340-346
85. Qiu JJ, Chang Z, Wu QJ, et al. Impact of volumetric modulated arc therapy technique on treatment with partial breast irradiation. Int J Radiat Oncol Biol Phys. 2010;78(1):288-296
86. Shaitelman SF, Kim LH, Yan D, et al. Continuous arc rotation of the couch therapy for the delivery of accelerated partial breast irradiation: a treatment planning analysis. Int J Radiat Oncol Biol Phys. 2011;80(3):771-778
87. Hamid S, Rocchio K, Arthur D, et al. A Multi-Institutional Study of Feasibility, Implementation, and Early Clinical Results with Noninvasive Breast Brachytherapy for Tumor Bed Boost. Int J Radiat Oncol Biol Phys. 2012;83(5):1374-1380
88. Yang Y, Rivard MJ. Monte Carlo simulations and radiation dosimetry measurements of peripherally applied HDR 192Ir breast brachytherapy D-shaped applicators. Med Phys. 2009;36(3):809-815
89. Wang X, Amos RA, Zhang X, et al. External-beam accelerated partial breast irradiation using multiple proton beam configurations. Int J Radiat Oncol Biol Phys. 2011;80(5):1464-1472
90. Lemanski C, Azria D, Gourgon-Bourgade S, et al. Intraoperative radiotherapy in early-stage breast cancer: results of the montpellier phase II trial. Int J Radiat Oncol Biol Phys. 2010;76(3):698-703
91. Vaidya JS, Baum M, Tobias JS, et al. Long-term results of targeted intraoperative radiotherapy (targit) boost during breast-conserving surgery. Int J Radiat Oncol Biol Phys. 2011;81(4):1091-1097
92. Vaidya JS, Joseph DJ, Tobias JS, et al. Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): an international, prospective, randomised, non-inferiority phase 3 trial. Lancet. 2010;376(9735):91-102
93. Kimple RJ, Klauber-DeMore N, Kuzmiak CM, et al. Cosmetic outcomes for accelerated partial breast irradiation before surgical excision of early-stage breast cancer using single-dose intraoperative radiotherapy. Int J Radiat Oncol Biol Phys. 2011;79(2):400-407
94. Ciocca M, Orecchia R, Garibaldi C, et al. In vivo dosimetry using radiochromic films during intraoperative electron beam radiation therapy in early-stage breast cancer. Radiother Oncol. 2003;69(3):285-289
95. Dickler A, Ivanov O, Francescatti D. Intraoperative radiation therapy in the treatment of early-stage breast cancer utilizing xoft axxent electronic brachytherapy. World J Surg Oncol. 2009;7:24
96. Ivanov O, Dickler A, Lum BY, et al. Twelve-month follow-up results of a trial utilizing Axxent electronic brachytherapy to deliver intraoperative radiation therapy for early-stage breast cancer. Ann Surg Oncol. 2011;18(2):453-458
97. Dickler A, Kirk MC, Seif N, et al. A dosimetric comparison of MammoSite high-dose-rate brachytherapy and Xoft Axxent electronic brachytherapy. Brachytherapy. 2007;6(2):164-168
98. Mehta VK, Algan O, Griem KL, et al. Experience with an electronic brachytherapy technique for intracavitary accelerated partial breast irradiation. Am J Clin Oncol. 2010;33(4):327-335
99. Dooley WC, Wurzer JC, Megahy M, et al. Electronic brachytherapy as adjuvant therapy for early stage breast cancer: a retrospective analysis. Onco Targets Ther. 2011;4:13-20
100. Vaidya JS, Baum M, Tobias JS, et al. Targeted intra-operative radiotherapy (Targit): an innovative method of treatment for early breast cancer. Ann Oncol. 2001;12(8):1075-1080
101. Douglas RM, Beatty J, Gall K, et al. Dosimetric results from a feasibility study of a novel radiosurgical source for irradiation of intracranial metastases. Int J Radiat Oncol Biol Phys. 1996;36(2):443-450
102. Cosgrove GR, Hochberg FH, Zervas NT, et al. Interstitial irradiation of brain tumors, using a miniature radiosurgery device: initial experience. Neurosurgery. 1997;40(3):518-523; discussion 523-515
103. Vaidya JS, Tobias JS, Baum M, et al. Intraoperative radiotherapy for breast cancer. Lancet Oncol. 2004;5(3):165-173
104. Vaidya JS, Baum M, Tobias JS, et al. The novel technique of delivering targeted intraoperative radiotherapy (Targit) for early breast cancer. Eur J Surg Oncol. 2002;28(4):447-454
105. Herskind C, Griebel J, Kraus-Tiefenbacher U, et al. Sphere of equivalence: a novel target volume concept for intraoperative radiotherapy using low-energy X rays. Int J Radiat Oncol Biol Phys. 2008;72(5):1575-1581
106. Wenz F, Welzel G, Keller A, et al. Early initiation of external beam radiotherapy (EBRT) may increase the risk of long-term toxicity in patients undergoing intraoperative radiotherapy (IORT) as a boost for breast cancer. Breast. 2008;17(6):617-622
107. Andersen KG, Gartner R, Kroman N, et al. Persistent pain after targeted intraoperative radiotherapy (TARGIT) or external breast radiotherapy for breast cancer: a randomized trial. Breast. 2012;21(1):46-49.